Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announcement of Resolutions from the Third Meeting of the Ninth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or major omissions.
The notice for the third meeting of the ninth Board of Directors of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was delivered to all directors by person and email on April 16, 2026. The meeting was held on April 27, 2026, in the Company's meeting room through on-site and written voting. Nine directors were required to attend, and nine directors actually attended. The meeting was presided over by Mr. Chen Yonghong, Chairman of the Board, and the Secretary of the Board attended the meeting. The convening and holding of this meeting comply with the relevant provisions of laws, regulations, and the "Articles of Association." After careful deliberation by the attending directors, the following resolutions were made by means of a signed vote:
I. The "Proposal on Changes to Accounting Policies" was deliberated and approved.
The Company's change in accounting policies was made in accordance with the relevant notice from the Ministry of Finance, complying with the "Guiding No. 1 for Self-Regulation of Main Board Listed Companies" of the Shenzhen Stock Exchange and "Accounting Standards No. 28 – Changes in Accounting Policies, Accounting Estimates, and Correction of Errors." The revised accounting policies comply with the "Accounting Standards for Business Enterprises" and relevant regulations. The change in accounting policies will not have a significant impact on the Company's financial position, operating results, and cash flows. The Company's Board of Directors agrees to this change in accounting policies. Voting results: 9 votes in favor, 0 votes against, 0 abstentions. Note: For details, please refer to the information disclosure media: "Securities Times," "Shanghai Securities News," and the website of Juchao Information Network (www.cninfo.com.cn).
II. The "Company's 2025 President's Work Report" was deliberated and approved.
The President reported on the Company's operating conditions and outlook for the future to the Board of Directors. The Board of Directors approved this report. Voting results: 9 votes in favor, 0 votes against, 0 abstentions.
III. The "Company's 2025 Board of Directors' Work Report" was deliberated and approved. This report will be submitted to the Company's 2025 Shareholders' Meeting for deliberation. Voting results: 9 votes in favor, 0 votes against, 0 abstentions. Note: For details, please refer to the relevant content in Section III of the "2025 Annual Report" published by the Company on the Juchao Information Network (www.cninfo.com.cn).
The independent directors of the eighth Board of Directors, Ms. Mu Xiaorong, Mr. Lin Ruichao, and Mr. Wu Qinggong, and the independent directors of the ninth Board of Directors, Mr. Liu Yunguo, Ms. Tao Jianhong, and Mr. Jiang Baoguo, submitted their "Independent Directors' 2025 Performance Reports" to the Board of Directors, and will present them at the 2025 Shareholders' Meeting. For details, please refer to the information disclosure media: Juchao Information Network (www.cninfo.com.cn).
IV. The "Company's 2025 Profit Distribution Plan" was deliberated and approved. This proposal will be submitted to the Company's 2025 Shareholders' Meeting for deliberation.